- Home
- Publications
- Publication Search
- Publication Details
Title
HUNK phosphorylates EGFR to regulate breast cancer metastasis
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-09
DOI
10.1038/s41388-019-1046-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase
- (2018) Joelle N. Zambrano et al. Oncotarget
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
- (2016) Bryce W. Buchanan et al. Jove-Journal of Visualized Experiments
- Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer
- (2016) Kendall Phelps-Polirer et al. PLoS One
- Hunk/Mak-v is a negative regulator of intestinal cell proliferation
- (2015) Karen R Reed et al. BMC CANCER
- Role of ErbB Receptors in Cancer Cell Migration and Invasion
- (2015) Aline Appert-Collin et al. Frontiers in Pharmacology
- Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors
- (2014) Elizabeth S. Yeh et al. BREAST CANCER RESEARCH AND TREATMENT
- High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
- (2014) Heae Surng Park et al. MODERN PATHOLOGY
- Emerging protein kinase inhibitors for non-small cell lung cancer
- (2013) Stephen V Liu et al. EXPERT OPINION ON EMERGING DRUGS
- Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin
- (2013) Juan Manuel Iglesias et al. PLoS One
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Hunk is required for HER2/neu-induced mammary tumorigenesis
- (2011) Elizabeth S. Yeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
- (2011) P Yue et al. ONCOGENE
- Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
- (2010) M K Wendt et al. ONCOGENE
- HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1
- (2010) M. Quintela-Fandino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis
- (2009) G. B. W. Wertheim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- ErbB receptors and cell polarity: New pathways and paradigms for understanding cell migration and invasion
- (2008) Michael E. Feigin et al. EXPERIMENTAL CELL RESEARCH
- Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer
- (2008) Susanne Hipp et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now